These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 22151628)

  • 1. Are prescribing doctors sensitive to the price that their patients have to pay in the Spanish National Health System?
    González López-Valcárcel B; Librero J; Sanfélix-Gimeno G; Peiró S;
    BMC Health Serv Res; 2011 Dec; 11():333. PubMed ID: 22151628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of a change in co-payment on prescription drug demand in a National Health System: The case of 15 drug families by price elasticity of demand.
    Hernández-Izquierdo C; González López-Valcárcel B; Morris S; Melnychuk M; Abásolo Alessón I
    PLoS One; 2019; 14(3):e0213403. PubMed ID: 30917142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing the effects of drug price reduction policies on older people in Taiwan.
    Chu HL; Liu SZ; Romeis JC
    Health Serv Manage Res; 2011 Feb; 24(1):1-7. PubMed ID: 21285360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of an Rx-to-OTC switch on medication prescribing patterns and utilization of physician services: the case of vaginal antifungal products.
    Gurwitz JH; McLaughlin TJ; Fish LS
    Health Serv Res; 1995 Dec; 30(5):672-85. PubMed ID: 8537226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of copayment policies on initial medication non-adherence according to income: a population-based study.
    Aznar-Lou I; Pottegård A; Fernández A; Peñarrubia-María MT; Serrano-Blanco A; Sabés-Figuera R; Gil-Girbau M; Fajó-Pascual M; Moreno-Peral P; Rubio-Valera M
    BMJ Qual Saf; 2018 Nov; 27(11):878-891. PubMed ID: 29545326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Population analysis by area of health of changes in consumption, price and expenditure of cardiovascular drugs in eight autonomous communities, Spain, 2005].
    Sanfélix-Gimeno G; Peiró S; Librero J; Ausejo-Segura M; Suárez-Alemán C; Molina-López T; Concepción CM; Castaño-Riera E;
    Rev Esp Salud Publica; 2010; 84(4):389-407. PubMed ID: 21141266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physician awareness of drug cost: a systematic review.
    Allan GM; Lexchin J; Wiebe N
    PLoS Med; 2007 Sep; 4(9):e283. PubMed ID: 17896856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physician and Patient Adjustment to Reference Pricing for Drugs.
    Robinson JC; Whaley C; Brown TT; Dhruva SS
    JAMA Netw Open; 2020 Feb; 3(2):e1920544. PubMed ID: 32022881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dutch GPs' perceptions: the influence of out-of-pocket costs on prescribing.
    Kasje WN; Timmer JW; Boendermaker PM; Haaijer-Ruskamp FM
    Soc Sci Med; 2002 Nov; 55(9):1571-8. PubMed ID: 12297243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Positive and negative aspects of pharmaceutical services in Spain: about antidepressants and antipsychotics].
    Girona-Brumós L; Ribera-Montañá R; Juárez-Giménez JC; Pilar Lalueza-Broto M
    Gac Sanit; 2006 Mar; 20 Suppl 1():143-53. PubMed ID: 16539977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cost of freezing general practice.
    Harrison C; Bayram C; Miller GC; Britt HC
    Med J Aust; 2015 Apr; 202(6):313-6. PubMed ID: 25832157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improving physicians' knowledge of the costs of common medications and willingness to consider costs when prescribing.
    Korn LM; Reichert S; Simon T; Halm EA
    J Gen Intern Med; 2003 Jan; 18(1):31-7. PubMed ID: 12534761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benefit plan design and prescription drug utilization among asthmatics: do patient copayments matter?
    Crown WH; Berndt ER; Baser O; Finkelstein SN; Witt WP; Maguire J; Haver KE
    Front Health Policy Res; 2004; 7():95-127. PubMed ID: 15612337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent trends in the prescribing of cholesterol lowering drugs in Australia. A report from the Drug Utilization Subcommittee of the Pharmaceutical Benefits Advisory Committee.
    Henry DA; Cully LR; Grigson T; Lee C
    Med J Aust; 1991 Sep; 155(5):332-6. PubMed ID: 1895979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Family physician attitudes about prescribing using a drug formulary.
    Suggs LS; Raina P; Gafni A; Grant S; Skilton K; Fan A; Szala-Meneok K
    BMC Fam Pract; 2009 Oct; 10():69. PubMed ID: 19835601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health information technology and physicians' knowledge of drug costs.
    Tseng CW; Brook RH; Alexander GC; Hixon AL; Keeler EB; Mangione CM; Chen R; Jackson EA; Dudley RA
    Am J Manag Care; 2010 Apr; 16(4):e105-10. PubMed ID: 20370310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physicians, pharmaceutical sales representatives, and the cost of prescribing.
    Caudill TS; Johnson MS; Rich EC; McKinney WP
    Arch Fam Med; 1996 Apr; 5(4):201-6. PubMed ID: 8769907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Psychotropic drugs prescription to elderly people in the national institute of social services for retirees and pensioners of argentina (PAMI)].
    Bustin J; Triskier F; Arakaki J; Pérez Blanco J; Urtasun M; Cañás M; Gaido E; Estigarribia N; Regueiro A; Zamora R; Mastai R; Zamora R
    Vertex; 2019; XXX(143):70-78. PubMed ID: 31968033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Drug expenditures of pensioners in 1997-2000].
    Swistak P; Błońska-Fajfrowska B
    Wiad Lek; 2003; 56(1-2):85-8. PubMed ID: 12901276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The outpatient utilization of non-steroidal anti-inflammatory drugs in South Bačka District, Serbia.
    Calasan J; Mijatović V; Horvat O; Varga J; Sabo A; Stilinović N
    Int J Clin Pharm; 2011 Apr; 33(2):246-51. PubMed ID: 21744192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.